SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 424B5
Document Type: 424B5
Date Filed: 2025-12-09
Accession Number: 0001213900-25-119671
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025119671/ea0268926-424b5_synergy.htm

Chunk 14 of 23
Word Count: 1482
Character Count: 9432

Document Content:

investment-grade securities. THE SECURITIES WE MAY OFFER General The descriptions of the securities contained in this prospectus, together with the applicable prospectus supplements, summarize all of the material terms and provisions of the various types of securities that we may offer. We will describe in the applicable prospectus supplement relating to any securities the particular terms of the securities offered by that prospectus supplement. If we indicate in the applicable prospectus supplement, the terms of the securities may differ from the terms we have summarized below. We may also include in the prospectus supplement information about material United States federal income tax considerations relating to the securities, and the securities exchange, if any, on which the securities will be listed. We may sell from time to time, in one or more offerings: ● common stock; ● preferred stock; ● warrants to purchase shares of our common stock or preferred stock;

●	debt securities;

●	subscription rights to purchase shares of common stock, preferred stock or debt securities; and

●	units consisting of any combination of the securities listed above.

In this prospectus, we refer
to the common stock, preferred stock, warrants, debt securities, subscription rights and units collectively as “securities.”
The total dollar amount of all securities that we may sell pursuant to this prospectus will not exceed $100 million.

If we issue debt securities
at a discount from their original stated principal amount, then, for purposes of calculating the total dollar amount of all securities
issued under this prospectus, we will treat the initial offering price of the debt securities as the total original principal amount of
the debt securities.

This prospectus may not be
used to consummate a sale of securities unless it is accompanied by a prospectus supplement.

DESCRIPTION OF CAPITAL
STOCK

The following descriptions
are summaries of the material terms of our certificate of incorporation and amended and restated bylaws, to which you should refer. Reference
is made to the more detailed provisions of, and the descriptions are qualified in their entirety by reference to, the certificate of incorporation
and amended and restated bylaws, which are filed with the SEC as exhibits to the registration statement of which this prospectus is a
part, and applicable law.

General

Our authorized capital stock
consists of 300,000,000 shares of common stock, par value $0.00001 per share and 1,000,000 shares of undesignated preferred
stock, $0.00001 par value. On November 20, 2025 there were 11,431,926 shares of common stock issued and 11,251,853 shares of common stock
outstanding, held by approximately 68 stockholders of record. On November 20, 2025, no shares of preferred stock were issued or outstanding.

Common Stock

Dividend Rights

The holders of outstanding
shares of our common stock are entitled to receive dividends out of funds legally available at the times and in the amounts that our Board
of Directors may determine.

Voting Rights

Each holder of our common stock
is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Cumulative voting for
the election of directors is not provided for in our articles of incorporation, which means that the holders of a majority of our shares
of common stock voted can elect all of the directors then standing for election.

Preemptive or Similar Rights

Our common stock is not entitled
to preemptive rights and is not subject to conversion or redemption.

Liquidation Rights

Upon our liquidation, dissolution,
or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our
common stock outstanding at that time after payment of other claims of creditors.

Preferred Stock

Our articles of incorporation
provide that our Board of Directors is authorized to issue shares of preferred stock from time to time in one or more series. Our Board
of Directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional
or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series.

We will fix the designations,
powers, preferences and rights of the preferred stock of each series, as well as the qualifications, limitations or restrictions thereon,
in the certificate of designation relating to that series. The applicable prospectus supplement will contain the terms of and other information
relating to the preferred stock which will include, as applicable:

●	the title and stated value;

●	the number of shares we are offering;

●	the liquidation preference per share;

●	the purchase price; the dividend rate, period and payment date
and method of calculation for dividends;

●	whether dividends will be cumulative or non-cumulative and,
if cumulative, the date from which dividends will accumulate;

●	the procedures for any auction and remarketing, if any;

●	the provisions for a sinking fund, if any;

●	the provisions for redemption or repurchase, if applicable,
and any restrictions on our ability to exercise those redemption and repurchase rights;

●	any listing of the preferred stock on any securities exchange
or market;

●	whether the preferred stock will be convertible into our common
stock, and, if applicable, the conversion price, or how it will be calculated, and the conversion period;

●	voting rights, if any, of the preferred stock;

●	preemptive rights, if any;

●	restrictions on transfer, sale or other assignment, if any;

●	whether interests in the preferred stock will be represented
by depositary shares;

●	a discussion of any material United States federal income tax
considerations applicable to the preferred stock;

●	the relative ranking and preferences of the preferred stock
as to dividend rights and rights if we liquidate, dissolve or wind up our affairs;

●	any limitations on the issuance of any class or series of preferred
stock ranking senior to or on a parity with the series of preferred stock as to dividend rights and rights if we liquidate, dissolve
or wind up our affairs; and

●	any other specific terms, preferences, rights or limitations
of, or restrictions on, the preferred stock.

Our Board of Directors is able
to, without stockholder approval, issue preferred stock with voting and other rights that could adversely affect the voting power and
other rights of the holders of the common stock and could have anti-takeover effects. The ability of our Board of Directors to issue preferred
stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of us or the removal
of existing management. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of our common
stock.

We have no preferred stock
outstanding at the date hereof.

Anti-Takeover Effects of Certain Provisions
of Nevada Law

Effect of Nevada Anti-takeover Statute.
We are subject to Section 78.438 of the Nevada Revised Statutes, an anti-takeover law. In general, Section 78.438 prohibits
a Nevada corporation from engaging in any business combination with any interested stockholder for a period of two years following
the date that the stockholder became an interested stockholder, unless prior to that date, the board of directors of the corporation approved
either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder, or if after the
date that the stockholder becomes an interested stockholder the business combination is approved by the board of directors and by 60%
of the voting power of all disinterested stockholders at either an annual or special meeting of the stockholders of the corporation. Section 78.439
provides that business combinations after the two-year period following the date that the stockholder becomes an interested stockholder
may also be prohibited unless either approved by the corporation’s directors before the stock acquisition, or by a majority of the
disinterested stockholders or unless the price and terms of the transaction meet other criteria set forth in the statute.

Section 78.416 defines “business
combination” to include the following:

●	any merger or consolidation involving the corporation and the
interested stockholder or any other corporation which is an affiliate or associate of the interested stockholder;

●	any sale, transfer, pledge or other disposition of the assets
of the corporation involving the interested stockholder or any affiliate or associate of the interested stockholder if the assets transferred
have a market value equal to 5% or more of all of the assets of the corporation or 5% or more of the value of the outstanding shares
of the corporation or represent 10% or more of the earning power of the corporation;

●	subject to certain exceptions, any transaction that results
in the issuance or transfer by the corporation of any stock of the corporation to an interested stockholder, with a market value of 5%
or more of the value of the outstanding shares of the corporation;

●	the adoption of a plan of liquidation proposed by or under any
arrangement with the interested stockholder or any affiliate or associate of the interested stockholder;